GEP20012487B - Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose
- Google Patents
Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose
Info
Publication number
GEP20012487B
GEP20012487BGEAP19984490AGEAP1998004490AGEP20012487BGE P20012487 BGEP20012487 BGE P20012487BGE AP19984490 AGEAP19984490 AGE AP19984490AGE AP1998004490 AGEAP1998004490 AGE AP1998004490AGE P20012487 BGEP20012487 BGE P20012487B
Authority
GE
Georgia
Prior art keywords
carbarnoyl
dibenz
azepin
analogues
derivatives
Prior art date
Application number
GEAP19984490A
Inventor
Merab Lomia
Original Assignee
Merab Lomia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merab LomiafiledCriticalMerab Lomia
Priority to GEAP19984490ApriorityCriticalpatent/GEP20012487B/en
Publication of GEP20012487BpublicationCriticalpatent/GEP20012487B/en
1. Technical Result Increase in efficiency of treatment, reduction of side-effects, providing the stable remission and cure. 2. Essence A chemical agent 5-carbarnoyl-5H-dibenz (b,f) azepin, its derivatives and analogues are used for treating bronchial asthma, bronchospastic syndrome and diseases with such a syndrome. 3. Field of Application Medicine, therapy.
GEAP19984490A1998-09-161998-09-16Use of Chemical Agent 5-carbarnoyl-5H-Dibenz (b,f) azepin, its Derivatives and Analogues by New Purpose
GEP20012487B
(en)
Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases
USE OF ASCORBIL-GAMMA-LINOLENATE OR ASCORBIL-DIHOMO-GAMMA-LINOLENATE FOR THE TREATMENT OF ASTHMA, CANCER, CARDIOVASCULAR DISEASES AND ANTI-INFLAMMATORIES.